Suzhou Dawnrays Pharmaceutical Co., Ltd.

Dawnrays has been listed on the Main Board of Hong Kong Stock Exchange Market.The Group is engaged in the development, manufacturing and the sale of cephalosporin antibiotics, and various system specific medicines (generic drugs). Dawnrays has boosted its production capacity of cephalosporin bulk medicine to 1000 tons/year, and it is expected to be… More